vs
亚什兰（ASH）与STONERIDGE INC（SRI）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是STONERIDGE INC的1.9倍（$386.0M vs $205.2M），亚什兰同比增速更快（-4.7% vs -6.0%），亚什兰自由现金流更多（$111.0M vs $2.6M），过去两年STONERIDGE INC的营收复合增速更高（-7.4% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Stoneridge Inc是全球领先的电气电子元件、集成系统及传感器解决方案设计制造商，服务汽车、商用车、非道路设备与航空航天领域，产品可提升车辆安全性、运行效率、互联性与环保表现，业务覆盖全球核心市场。
ASH vs SRI — 直观对比
营收规模更大
ASH
是对方的1.9倍
$205.2M
营收增速更快
ASH
高出1.3%
-6.0%
自由现金流更多
ASH
多$108.4M
$2.6M
两年增速更快
SRI
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $205.2M |
| 净利润 | $-12.0M | — |
| 毛利率 | 27.2% | 16.2% |
| 营业利润率 | -1.6% | -14.4% |
| 净利率 | -3.1% | — |
| 营收同比 | -4.7% | -6.0% |
| 净利润同比 | 92.7% | — |
| 每股收益（稀释后） | $-0.26 | $-2.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHSRI
| Q4 25 | $386.0M | $205.2M | ||
| Q3 25 | $477.0M | $210.3M | ||
| Q2 25 | $463.0M | $228.0M | ||
| Q1 25 | $479.0M | $217.9M | ||
| Q4 24 | $405.0M | $218.2M | ||
| Q3 24 | $521.0M | $213.8M | ||
| Q2 24 | $544.0M | $237.1M | ||
| Q1 24 | $575.0M | $239.2M |
净利润ASHSRI
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $31.0M | $-9.4M | ||
| Q2 25 | $-742.0M | $-9.4M | ||
| Q1 25 | $31.0M | $-7.2M | ||
| Q4 24 | $-165.0M | — | ||
| Q3 24 | $17.0M | $-7.1M | ||
| Q2 24 | $6.0M | $2.8M | ||
| Q1 24 | $120.0M | $-6.1M |
毛利率ASHSRI
| Q4 25 | 27.2% | 16.2% | ||
| Q3 25 | 33.3% | 20.3% | ||
| Q2 25 | 28.5% | 21.5% | ||
| Q1 25 | 30.7% | 21.2% | ||
| Q4 24 | 27.4% | 19.5% | ||
| Q3 24 | 33.2% | 20.8% | ||
| Q2 24 | 34.2% | 22.7% | ||
| Q1 24 | 28.0% | 20.2% |
营业利润率ASHSRI
| Q4 25 | -1.6% | -14.4% | ||
| Q3 25 | 12.8% | -1.6% | ||
| Q2 25 | -152.9% | -1.1% | ||
| Q1 25 | 10.6% | -1.5% | ||
| Q4 24 | -44.2% | -2.0% | ||
| Q3 24 | 6.1% | 0.1% | ||
| Q2 24 | -11.2% | 1.4% | ||
| Q1 24 | 3.7% | 0.1% |
净利率ASHSRI
| Q4 25 | -3.1% | — | ||
| Q3 25 | 6.5% | -4.5% | ||
| Q2 25 | -160.3% | -4.1% | ||
| Q1 25 | 6.5% | -3.3% | ||
| Q4 24 | -40.7% | — | ||
| Q3 24 | 3.3% | -3.3% | ||
| Q2 24 | 1.1% | 1.2% | ||
| Q1 24 | 20.9% | -2.6% |
每股收益（稀释后）ASHSRI
| Q4 25 | $-0.26 | $-2.76 | ||
| Q3 25 | $0.83 | $-0.34 | ||
| Q2 25 | $-16.21 | $-0.34 | ||
| Q1 25 | $0.65 | $-0.26 | ||
| Q4 24 | $-3.50 | $-0.22 | ||
| Q3 24 | $0.34 | $-0.26 | ||
| Q2 24 | $0.12 | $0.10 | ||
| Q1 24 | $2.39 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $66.3M |
| 总债务越低越好 | $1.4B | $180.9M |
| 股东权益账面价值 | $1.9B | $179.8M |
| 总资产 | $4.5B | $551.2M |
| 负债/权益比越低杠杆越低 | 0.74× | 1.01× |
8季度趋势，按日历期对齐
现金及短期投资ASHSRI
| Q4 25 | $304.0M | $66.3M | ||
| Q3 25 | $215.0M | $54.0M | ||
| Q2 25 | $207.0M | $49.8M | ||
| Q1 25 | $168.0M | $79.1M | ||
| Q4 24 | $219.0M | $71.8M | ||
| Q3 24 | $300.0M | $54.1M | ||
| Q2 24 | $399.0M | $42.1M | ||
| Q1 24 | $439.0M | $48.4M |
总债务ASHSRI
| Q4 25 | $1.4B | $180.9M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $201.6M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
股东权益ASHSRI
| Q4 25 | $1.9B | $179.8M | ||
| Q3 25 | $1.9B | $251.2M | ||
| Q2 25 | $1.9B | $260.5M | ||
| Q1 25 | $2.6B | $253.1M | ||
| Q4 24 | $2.6B | $245.3M | ||
| Q3 24 | $2.9B | $271.4M | ||
| Q2 24 | $3.0B | $270.5M | ||
| Q1 24 | $3.1B | $277.3M |
总资产ASHSRI
| Q4 25 | $4.5B | $551.2M | ||
| Q3 25 | $4.6B | $632.1M | ||
| Q2 25 | $4.6B | $639.4M | ||
| Q1 25 | $5.2B | $657.4M | ||
| Q4 24 | $5.2B | $621.6M | ||
| Q3 24 | $5.6B | $662.5M | ||
| Q2 24 | $5.7B | $666.7M | ||
| Q1 24 | $5.9B | $675.4M |
负债/权益比ASHSRI
| Q4 25 | 0.74× | 1.01× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | 0.82× | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $8.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $2.6M |
| 自由现金流率自由现金流/营收 | 28.8% | 1.3% |
| 资本支出强度资本支出/营收 | 3.6% | 3.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $12.2M |
8季度趋势，按日历期对齐
经营现金流ASHSRI
| Q4 25 | $125.0M | $8.8M | ||
| Q3 25 | $40.0M | $3.6M | ||
| Q2 25 | $115.0M | $10.7M | ||
| Q1 25 | $9.0M | $10.9M | ||
| Q4 24 | $-30.0M | $19.2M | ||
| Q3 24 | $80.0M | $10.8M | ||
| Q2 24 | $127.0M | $8.7M | ||
| Q1 24 | $54.0M | $9.1M |
自由现金流ASHSRI
| Q4 25 | $111.0M | $2.6M | ||
| Q3 25 | $6.0M | $-2.7M | ||
| Q2 25 | $95.0M | $7.4M | ||
| Q1 25 | $-12.0M | $4.8M | ||
| Q4 24 | $-53.0M | $14.0M | ||
| Q3 24 | $42.0M | $4.6M | ||
| Q2 24 | $98.0M | $1.5M | ||
| Q1 24 | $20.0M | $3.3M |
自由现金流率ASHSRI
| Q4 25 | 28.8% | 1.3% | ||
| Q3 25 | 1.3% | -1.3% | ||
| Q2 25 | 20.5% | 3.3% | ||
| Q1 25 | -2.5% | 2.2% | ||
| Q4 24 | -13.1% | 6.4% | ||
| Q3 24 | 8.1% | 2.2% | ||
| Q2 24 | 18.0% | 0.6% | ||
| Q1 24 | 3.5% | 1.4% |
资本支出强度ASHSRI
| Q4 25 | 3.6% | 3.0% | ||
| Q3 25 | 7.1% | 3.0% | ||
| Q2 25 | 4.3% | 1.4% | ||
| Q1 25 | 4.4% | 2.8% | ||
| Q4 24 | 5.7% | 2.4% | ||
| Q3 24 | 7.3% | 2.9% | ||
| Q2 24 | 5.3% | 3.0% | ||
| Q1 24 | 5.9% | 2.4% |
现金转化率ASHSRI
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | 3.11× | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
